1. Home
  2. HLMN vs TSHA Comparison

HLMN vs TSHA Comparison

Compare HLMN & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hillman Solutions Corp.

HLMN

Hillman Solutions Corp.

HOLD

Current Price

$8.76

Market Cap

1.7B

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$5.24

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLMN
TSHA
Founded
1964
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HLMN
TSHA
Price
$8.76
$5.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$12.20
$10.22
AVG Volume (30 Days)
978.1K
3.5M
Earning Date
02-17-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
388.43
N/A
EPS
0.19
N/A
Revenue
$1,536,647,000.00
$6,310,000.00
Revenue This Year
$7.97
N/A
Revenue Next Year
$7.80
N/A
P/E Ratio
$45.85
N/A
Revenue Growth
4.47
N/A
52 Week Low
$6.55
$1.05
52 Week High
$10.64
$6.02

Technical Indicators

Market Signals
Indicator
HLMN
TSHA
Relative Strength Index (RSI) 46.01 48.63
Support Level $8.81 $5.58
Resistance Level $9.11 $6.02
Average True Range (ATR) 0.23 0.26
MACD -0.03 -0.07
Stochastic Oscillator 26.63 9.88

Price Performance

Historical Comparison
HLMN
TSHA

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: